Corey lactone 4-phenylbenzoate or (3aR4S5R6aS)-hexahydro-4-(hydroxymethyl)-5-(4-phenylbenzoyloxy)cyclopenta[b]furan-2-one is a synthetic intermediate used in the manufacture of some prostaglandin derivatives.
List of articles in "Drug" category - Page 81
SR-144528
SR144528 is a drug that acts as a potent and highly selective CB2 receptor inverse agonist with a Ki of 0.6nM at CB2 and 400nM at the related CB1 receptor. […]
Traxoprodil
Traxoprodil (CP-101606) is a drug developed by Pfizer which acts as an NMDA antagonist selective for the NR2B subunit. It has neuroprotective analgesic and anti-Parkinsonian effects in animal studies. Traxoprodil […]
Aliskiren/amlodipine
The drug combination aliskiren/amlodipine (INNs trade name Tekamlo) is an antihypertensive.
Midostaurin
Midostaurin (PKC412) is a multi-target protein kinase inhibitor being investigated for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). It is a semi-synthetic derivative of staurosporine an […]
TM-38837
TM38837 is a new small molecule inverse agonist/antagonist of the CB1 cannabinoid receptor. It is being developed for the treatment of obesity and metabolic disorders by 7TM Pharma. The company […]
Trimethoprim/polymyxin
The drug combination trimethoprim/polymyxin (INNs trade name Polytrim) is an antimicrobial solution for topical ophthalmic use in the treatment of acute bacterial conjunctivitis and blepharoconjunctivitis.
Atovaquone/proguanil
The drug combination atovaquone/proguanil (INNs trade names Malarone Malanil) is an antimalarial medication used in both the treatment and prevention of malaria commercially available from GlaxoSmithKline since 2000. Atovaquone alone […]
Hydrocodone/ibuprofen
The drug combination hydrocodone/ibuprofen (INNs trade name Vicoprofen) is an analgesic medication used in short-term therapy to relieve severe pain. Hydrocodone is used in form of the bitartrate. This combination […]
Trastuzumab emtansine
Trastuzumab emtansine (INN; in the United States ado-trastuzumab emtansine trade name Kadcyla) is an antibody-drug conjugate consisting of the monoclonal antibody trastuzumab (Herceptin) linked to the cytotoxic agent mertansine (DM1). […]